aTYR PHARMA
San Diego, US
Biotech
Founders & leadership
AC
Amir C. NashatNon-Management Director
PC
Paul C. SchimmelNon-Management Director
AC
Akkaraju C. SrinivasNon-Management Director
JD
John D. MendleinExecutive Officer, Director
DC
David C. WeinerExecutive Officer
EC
Ed C. PenhoetNon-Management Director
FC
Frederic C. ChereauExecutive Officer
KC
Kathryn C. FalbergNon-Management Director
JC
James C. BlairNon-Management Director
JK
John K. ClarkeNon-Management Director
Reported raises · per SEC filings
Form D private placements$45.8MraisedSep 2017 · 11 investors · Biotechnology
Rule 506(b)$76.3MraisedApr 2015 · 42 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.